Participants 72 185 6
140 patients with a threatening premature birth at the greater than or equal to 24-less than 37 week of gestation
Participants 258 316 4
77% in the hexoprenalin and in 74% in the salbutamol group
Participants 321 378 4
weight of the newborn was greater than or equal to 2500 g
Participants 605 642 5
the mothers in the hexoprenalin group
